# A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

> **NCT00637481** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 66 (actual)

## Conditions studied

- Atypical Ductal Breast Hyperplasia
- Breast Cancer
- Ductal Breast Carcinoma in Situ
- Lobular Breast Carcinoma in Situ

## Interventions

- **DRUG:** atorvastatin calcium
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00637481
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2016-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00637481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00637481, "A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00637481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*